Die Kardiologie Kardiologiehttps://doi.org/10.1007/s12181-022-00568-yAngenommen:7.Juli2022 Schrittmacher- und kardiale Resynchronisationstherapie
暂无分享,去创建一个
[1] G. Sinagra,et al. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.
[2] C. Israel,et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. , 2021, European heart journal.
[3] I. V. Van Gelder,et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. , 2021, European heart journal.
[4] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[5] J. Deharo,et al. Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole , 2020, European heart journal.
[6] C. Stettler,et al. Cryoablation vs. radiofrequency ablation of the atrioventricular node in patients with His-bundle pacing. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[7] J. Rodés‐Cabau,et al. Intraprocedural high‐degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[8] Marco Valgimigli,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.
[9] M. Akçakaya,et al. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis. , 2019, Circulation. Arrhythmia and electrophysiology.
[10] C. Kwok,et al. Trends of Sex Differences in Outcomes of Cardiac Electronic Device Implantations in the United States. , 2019, The Canadian journal of cardiology.
[11] M. Táborský,et al. Practical conclusions from the new 2018 ESC Guidelines for the diagnosis and management of syncope , 2019, Medicína pro praxi.
[12] Christophe Leclercq,et al. 2018 ESC Guidelines for the diagnosis and management of syncope , 2018, European heart journal.
[13] S. Ernst,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[14] Wojciech Zareba,et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. , 2017, Heart rhythm.
[15] M. Brignole,et al. Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes. , 2015, European heart journal.
[16] B. Wilkoff,et al. The Epidemic of Inadequate Biventricular Pacing in Patients With Persistent or Permanent Atrial Fibrillation and Its Association With Mortality , 2014, Circulation. Arrhythmia and electrophysiology.
[17] J. Deharo,et al. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study. , 2013, Archives of cardiovascular diseases.
[18] R. Ruiz-Granell,et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block , 2011, European heart journal.
[19] S. Solomon,et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. , 2011, Journal of the American College of Cardiology.
[20] Nick Freemantle,et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. , 2006, European heart journal.
[21] H. Keller. Weiterführende Literatur , 2003, Das Reformationsjubiläum 2017.
[22] G. Lamas,et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.
[23] Jeroen J. Bax,et al. European Society of Cardiology: Cardiovascular Disease Statistics 2017. , 2018, European heart journal.
[24] Richard L. Verrier,et al. ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiacmonitoring / telemetry , 2017 .
[25] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[26] P. Singh. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. , 2014, The New England journal of medicine.